Lipoprotein(a) in Coronary Artery Bypass Graft Surgery Patients: An Underappreciated Opportunity to Optimise Cardiovascular Disease Prevention

Heart Lung Circ. 2021 Sep;30(9):e106-e107. doi: 10.1016/j.hlc.2021.03.280. Epub 2021 May 7.

¹ Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, The University of Western Australia, Perth, WA, Australia; Medical School, The University of Western Australia, Perth, WA, Australia. Electronic address: [email protected].
² Department of Cardiology, Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, The University of Western Australia, Perth, WA, Australia; Medical School, The University of Western Australia, Perth, WA, Australia.
³ Medical School, The University of Western Australia, Perth, WA, Australia; Departments of Clinical Biochemistry, PathWest Laboratory Medicine, Royal Perth and Fiona Stanley Hospitals, Perth, WA, Australia; Department of Endocrinology and Cardiology, Royal Perth Hospital, Perth, WA, Australia; Department of Biochemistry, Clinipath Pathology, Perth, WA, Australia.

No abstract available

Keywords: Cardiac surgical procedures; Cardiovascular diseases; Coronary disease; Lipoprotein(a).

Publication types